MRI device developer Biophan Technologies said it has signed a letter of intent with two German biomedical researchers, Dr. Arno Bucker and Dr. Alexander Ruebben, to license their cardiovascular stent technology enabling accurate magnetic resonance angiography (MRA) of the interior of vascular stents.
The technology, developed through research at the University of Aachen in Germany, is designed to enable MRI visualizations of implanted stents to assess the occurrence of restenosis, according to Rochester, NY-based Biophan.
By AuntMinnie.com staff writersMay 16, 2005
Related Reading
Biophan unveils next-generation Squiggle, April 7, 2005
Biophan scores two patents, April 4, 2005
Biophan adds nanotechnology patent, March 18, 2005
Biophan launches trial for vena cava filter, March 14, 2005
Biophan bids for German device firm, January 7, 2005
Copyright © 2005 AuntMinnie.com
